When should an interim analysis be unblinded to the data monitoring committee?
J Clin Epidemiol
.
2010 Apr;63(4):350-2.
doi: 10.1016/j.jclinepi.2009.07.003.
Epub 2009 Sep 17.
Authors
J André Knottnerus
1
,
Mark G Spigt
Affiliation
1
Department of General Practice, Care and Public Health Research Institute (Caphri), Faculty of Health, Medicine and Life Sciences, Maastricht University, 6220 MD Maastricht, The Netherlands. andre.knottnerus@hag.unimaas.nl
PMID:
19762210
DOI:
10.1016/j.jclinepi.2009.07.003
No abstract available
MeSH terms
Biomedical Research*
Clinical Trials Data Monitoring Committees*
Data Interpretation, Statistical*
Disclosure*
Humans
Research Design
Time Factors